SCHEMBL569691

SCHEMBL569691

O=C(O)c1cc2ccccc2c(Br)c1O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 2/20 0.69
GRIN2A Q12879 2/20 0.69
GRIN2B Q13224 2/20 0.69
GRIN2C Q14957 2/20 0.69
POLB P06746 2/20 0.63
GPR35 Q9HC97 2/20 0.63
CYP2D6 P10635 1/20 0.59
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
RXFP1 Q9HBX9 1/20 0.57
HPGD P15428 3/20 0.53
HSD17B10 Q99714 3/20 0.53
LDHA P00338 1/20 0.53
THRB P10828 1/20 0.53
CYP2C9 P11712 1/20 0.53
TSHR P16473 1/20 0.53
ALOX12 P18054 1/20 0.53
ATIC P31939 1/20 0.53
HMGB1 P09429 1/20 0.53
CXCL12 P48061 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30943793 1.00 GRIN2D (0.69) GRIN2DGRIN2AGRIN2BGRIN2CPOLB
SCHEMBL9728234 0.98 GRIN2D (0.68) GRIN2DGRIN2AGRIN2BGRIN2CPOLB
SCHEMBL12193740 0.86 GPR35 (0.58) GRIN2DGRIN2AGRIN2BGRIN2CPOLB
SCHEMBL3391301 0.83 POLB (0.69) GRIN2DGRIN2AGRIN2BGRIN2CPOLB
SCHEMBL9728229 0.83 GRIN2D (0.50) GRIN2DGRIN2AGRIN2BGRIN2CPOLB
SCHEMBL569344 0.82 GRIN2D (1.00) GRIN2DGRIN2AGRIN2BGRIN2CPOLB
SCHEMBL989695 0.81 POLB (0.67) GRIN2DGRIN2AGRIN2BGRIN2CPOLB
SCHEMBL30382494 0.81 GRIN2A (0.68) GRIN2DGRIN2AGRIN2BGRIN2CPOLB
SCHEMBL569949 0.81 GRIN2A (0.68) GRIN2DGRIN2AGRIN2BGRIN2CPOLB
SCHEMBL950007 0.81 MEN1 (0.55) GRIN2DGRIN2AGRIN2BGRIN2CPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4224221-A Modifier composition for azo pigments based on 2-hydroxy-3-naphthoic acid AMERICAN CYANAMID COMPANY (US) 1980-09-23 US claimed
EP-4668315-A1 COMPOSITION FOR FORMING PROTECTIVE FILM FOR SEMICONDUCTOR CHIP MANUFACTURE, SEMICONDUCTOR SUBSTRATE, SEMICONDUCTOR CHIP, AND METHOD FOR MANUFACTURING SEMICONDUCTOR CHIP Nissan Chemical Corporation (JP) 2025-12-24 EP disclosed
US-20250361419-A1 COMPOSITION FOR FORMING COATING FILM FOR REMOVING FOREIGN MATTERS AND SEMICONDUCTOR SUBSTRATE NISSAN CHEMICAL CORPORATION (JP) 2025-11-27 US disclosed
EP-4629280-A1 COMPOSITION FOR FORMING COATING FILM FOR FOREIGN SUBSTANCE REMOVAL, AND SEMICONDUCTOR SUBSTRATE Nissan Chemical Corporation (JP) 2025-10-08 EP disclosed
CN-119404289-A Composition for forming coating film for removing foreign matter and semiconductor substrate 日产化学株式会社 2025-02-07 CN disclosed
WO-2023248946-A1 COMPOSITION FOR FORMING COATING FILM FOR FOREIGN SUBSTANCE REMOVAL, AND SEMICONDUCTOR SUBSTRATE 日産化学株式会社 2023-12-28 WO disclosed
CN-110366768-B Composition for forming coating film for removing foreign matter 日产化学株式会社 2023-09-26 CN disclosed
US-20230250314-A1 COMPOSITION FOR FORMING A COATING FILM FOR REMOVING FOREIGN MATTERS NISSAN CHEMICAL CORPORATION (JP) 2023-08-10 US disclosed
CN-116034453-A Composition for forming coating film for removing foreign matter 日产化学株式会社 2023-04-28 CN disclosed
US-11319514-B2 Composition for forming a coating film for removing foreign matters NISSAN CHEMICAL CORPORATION (JP) 2022-05-03 US disclosed
WO-2004056347-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING INSULIN AND LEGENDS OF INSULIN HEXAMER NOVO NORDISK A/S (DK) 2004-07-08 WO disclosed
EP-1429763-A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER NOVO NORDISK A/S (DK) 2004-06-23 EP disclosed
WO-2004036311-A2 ANTI-REFLECTIVE COMPOSITIONS COMPRISING TRIAZINE COMPOUNDS BREWER SCIENCE, INC. (US) 2004-04-29 WO disclosed
US-20040072420-A1 Anti-reflective compositions comprising triazine compounds BREWER SCIENCE, INC 2004-04-15 US disclosed
US-20030229120-A1 Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer NOVO NORDISK A/S (DK) 2003-12-11 US disclosed
WO-2003027081-A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER NOVO NORDISK A/S (DK) 2003-04-03 WO disclosed
EP-0327221-B1 PROCESS FOR PRODUCTION OF AROMATIC HYDROXYCARBOXYLIC ACID Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo (JP) 1993-03-31 EP disclosed
US-4966992-A REACTING ALKALI METAL PHENOLATE WITH CARBON DIOXIDE KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 1990-10-30 US disclosed
EP-0327221-A1 Process for production of aromatic hydroxycarboxylic acid Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo (JP) 1989-08-09 EP disclosed
US-4224221-A Modifier composition for azo pigments based on 2-hydroxy-3-naphthoic acid AMERICAN CYANAMID COMPANY (US) 1980-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229120-A1 Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer IAPP, IRS1, GPR119 GRIN2D 3134/4885GRIN2A 1751/4885GRIN2B 511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.